Semi-Crossover Randomised Controlled Trial Design
Cross-source consensus on Semi-Crossover Randomised Controlled Trial Design from 1 sources and 6 claims.
1 sources · 6 claims
How it works
Benefits
Dosage & preparation
Risks & contraindications
Highlighted claims
- The trial is a single-centre, open-label, semi-crossover RCT conducted at the Affiliated Lihuili Hospital of Ningbo University, with 28 participants randomised 1:1. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial
- Randomisation is stratified by IBD diagnosis (CD vs UC) using a randomised block design with block size 4. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial
- The total sample size of 28 participants accounts for an expected 30% dropout rate. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial
- The semi-crossover design provides an ethical advantage by ensuring control participants eventually receive the intervention and a statistical advantage through within-group comparisons. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial
- Full blinding of participants and researchers is not possible, but outcome assessors and laboratory personnel are kept unaware of group assignments. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial
- Trial limitations include small sample size, open-label design, and a 12-week intervention period that may be insufficient to assess sustained behavioural change or disease-modifying effects. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial